In summary, ten patient-derived NSCLC xenograft models were established harboring a variety of genetic aberrations including; EGFR activating and KRAS mutations, and FGFR1 and cMET gene amplification. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.